Host range restriction of insect-specific flaviviruses occurs at several levels of the viral life cycle

mSphere

Volumn 2, Issue 1, 2017, Pages

  Junglen, Sandra ^a   Korries, Marvin ^a,d   Grasse, Wolfgang ^b,e   Wieseler, Janett ^a   Kopp, Anne ^a   Hermanns, Kyra ^a   León Juárez, Moises ^a,f   Drosten, Christian ^a,c   Kümmerer, Beate Mareike ^a  

^a UNIVERSITY OF BONN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Biovis' Diagnostik MVZ GmbH   (Germany)

^e Sata GmbH and Co KG   (Germany)

^f Department of Immunobiochemistry   (Mexico)

Author keywords

Host range restriction; Infection barriers; Insect specific flavivirus

Indexed keywords

EID: 85019624255     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00375-16     Document Type: Article

References (52)

1. Asgari S, Johnson KN. 2010. Insect virology. Caister Academic Press, Poole, UK
2. Weaver SC, Reisen WK. 2010. Present and future arboviral threats. Antiviral Res 85:328-345. https://doi.org/10.1016/j.antiviral.2009.10.008
3. Bolling BG, Weaver SC, Tesh RB, Vasilakis N. 2015. Insect-specific virus discovery: significance for the arbovirus community. Viruses 7:4911-4928. https://doi.org/10.3390/v7092851
4. Vasilakis N, Tesh RB. 2015. Insect-specific viruses and their potential impact on arbovirus transmission. Curr Opin Virol 15:69-74. https:// doi.org/10.1016/j.coviro.2015.08.007
5. Marklewitz M, Zirkel F, Kurth A, Drosten C, Junglen S. 2015. Evolutionary and phenotypic analysis of live virus isolates suggests arthropod origin of a pathogenic RNA virus family. Proc Natl Acad Sci U S A 112: 7536-7541. https://doi.org/10.1073/pnas.1502036112
6. Cook S, Holmes EC. 2006. A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol 151:309-325. https://doi.org/ 10.1007/s00705-005-0626-6
7. Cook S, Moureau G, Kitchen A, Gould EA, de Lamballerie X, Holmes EC, Harbach RE. 2012. Molecular evolution of the insect-specific flaviviruses. J Gen Virol 93:223-234. https://doi.org/10.1099/vir.0.036525-0
8. Blitvich BJ, Firth AE. 2015. Insect-specific flaviviruses: a systematic review of their discovery, host range, mode of transmission, superinfection exclusion potential and genomic organization. Viruses 7:1927-1959. https://doi.org/10.3390/v7041927
9. Junglen S, Kopp A, Kurth A, Pauli G, Ellerbrok H, Leendertz FH. 2009. A new flavivirus and a new vector: characterization of a novel flavivirus isolated from uranotaenia mosquitoes from a tropical rain forest. J Virol 83:4462-4468. https://doi.org/10.1128/JVI.00014-09
10. Kolodziejek J, Pachler K, Bin H, Mendelson E, Shulman L, Orshan L, Nowotny N. 2013. Barkedji virus, a novel mosquito-borne flavivirus identified in Culex perexiguus mosquitoes, Israel, 2011. J Gen Virol 94:2449-2457. https://doi.org/10.1099/vir.0.056200-0
11. Huhtamo E, Putkuri N, Kurkela S, Manni T, Vaheri A, Vapalahti O, Uzcátegui NY. 2009. Characterization of a novel flavivirus from mosquitoes in northern Europe that is related to mosquito-borne flaviviruses of the tropics. J Virol 83:9532-9540. https://doi.org/10.1128/JVI.00529-09
12. Lindenbach BD, Murrey CL, Thiel H-J, Rice CM. 2013. Flaviviridae, p 712-746. In Knipe DM, Howley PM (ed), Fields virology, 6th ed, vol. 1. Lippincott Williams and Wilkins, Philadelphia, PA
13. Tree MO, McKellar DR, Kieft KJ, Watson AM, Ryman KD, Conway MJ. 2016. Insect-specific flavivirus infection is restricted by innate immunity in the vertebrate host. Virology 497:81-91. https://doi.org/10.1016/ j.virol.2016.07.005
14. Nasar F, Palacios G, Gorchakov RV, Guzman H, Da Rosa AP, Savji N, Popov VL, Sherman MB, Lipkin WI, Tesh RB, Weaver SC. 2012. Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A 109:14622-14627. https://doi.org/10.1073/ pnas.1204787109
15. Nasar F, Gorchakov RV, Tesh RB, Weaver SC. 2015. Eilat virus host range restriction is present at multiple levels of the virus life cycle. J Virol 89:1404-1418. https://doi.org/10.1128/JVI.01856-14
16. Firth AE, Blitvich BJ, Wills NM, Miller CL, Atkins JF. 2010. Evidence for ribosomal frameshifting and a novel overlapping gene in the genomes of insect-specific flaviviruses. Virology 399:153-166. https://doi.org/ 10.1016/j.virol.2009.12.033
17. Rice CM, Grakoui A, Galler R, Chambers TJ. 1989. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol 1:285-296
18. Vómann S, Wieseler J, Kerber R, Kümmerer BM. 2015. A basic cluster in the N terminus of yellow fever virus NS2A contributes to infectious particle production. J Virol 89:4951-4965. https://doi.org/10.1128/ JVI.03351-14
19. Bogerd HP, Whisnant AW, Kennedy EM, Flores O, Cullen BR. 2014. Derivation and characterization of dicer-and microRNA-deficient human cells. RNA 20:923-937. https://doi.org/10.1261/rna.044545.114
20. Garcia-Moreno M, Sanz MA, Carrasco L. 2016. A viral mRNA motif at the 3'-untranslated region that confers translatability in a cell-specific manner. Implications for virus evolution. Sci Rep 6:19217. https://doi.org/ 10.1038/srep19217
21. Amberg SM, Nestorowicz A, McCourt DW, Rice CM. 1994. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol 68:3794-3802
22. Snyder AJ, Sokoloski KJ, Mukhopadhyay S. 2012. Mutating conserved cysteines in the alphavirus e2 glycoprotein causes virus-specific assembly defects. J Virol 86:3100-3111. https://doi.org/10.1128/JVI.06615-11
23. Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM. 2012. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A 109:14610-14615. https://doi.org/ 10.1073/pnas.1212379109
24. Charlier N, Davidson A, Dallmeier K, Molenkamp R, De Clercq E, Neyts J. 2010. Replication of not-known-vector flaviviruses in mosquito cells is restricted by intracellular host factors rather than by the viral envelope proteins. J Gen Virol 91:1693-1697. https://doi.org/10.1099/vir.0.019851-0
25. Engel AR, Mitzel DN, Hanson CT, Wolfinbarger JB, Bloom ME, Pletnev AG. 2011. Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes. Vector Borne Zoonotic Dis 11:665-674. https://doi.org/10.1089/vbz.2010.0179
26. Friedrich S, Schmidt T, Geissler R, Lilie H, Chabierski S, Ulbert S, Liebert UG, Golbik RP, Behrens SE. 2014. AUF1 p45 promotes West Nile virus replication by an RNA chaperone activity that supports cyclization of the viral genome. J Virol 88:11586-11599. https://doi.org/10.1128/JVI.01283-14
27. Blackwell JL, Brinton MA. 1997. Translation elongation factor-1 alpha interacts with the 3' stem-loop region of West Nile virus genomic RNA. J Virol 71:6433-6444
28. De Nova-Ocampo M, Villegas-Sepúlveda N, del Angel RM. 2002. Translation elongation factor-1alpha, La, and PTB interact with the 3' untranslated region of dengue 4 virus RNA. Virology 295:337-347. https:// doi.org/10.1006/viro.2002.1407
29. Qing M, Yang F, Zhang B, Zou G, Robida JM, Yuan Z, Tang H, Shi PY. 2009. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother 53:3226-3235. https://doi.org/10.1128/AAC.00189-09
30. Emara MM, Brinton MA. 2007. Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc Natl Acad Sci U S A 104:9041-9046. https://doi.org/10.1073/pnas.0703348104
31. de Medeiros RB, Figueiredo J, Resende Rde O, De Avila AC. 2005. Expression of a viral polymerase-bound host factor turns human cell lines permissive to a plant-and insect-infecting virus. Proc Natl Acad Sci U S A 102:1175-1180. https://doi.org/10.1073/pnas.0406668102
32. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581. https://doi.org/10.1126/science.1113329
33. Scheel TK, Luna JM, Liniger M, Nishiuchi E, Rozen-Gagnon K, Shlomai A, Auray G, Gerber M, Fak J, Keller I, Bruggmann R, Darnell RB, Ruggli N, Rice CM. 2016. A Broad RNA virus survey reveals both miRNA dependence and functional sequestration. Cell Host Microbe 19:409-423. https://doi.org/10.1016/j.chom.2016.02.007
34. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saïb A, Voinnet O. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560. https://doi.org/10.1126/science .1108784
35. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. 2009. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34:696-709. https://doi.org/10.1016/j.molcel.2009.06.003
36. Song L, Liu H, Gao S, Jiang W, Huang W. 2010. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 84: 8849-8860. https://doi.org/10.1128/JVI.00456-10
37. Villordo SM, Filomatori CV, Sánchez-Vargas I, Blair CD, Gamarnik AV. 2015. Dengue virus RNA structure specialization facilitates host adaptation. PLoS Pathog 11:e1004604. https://doi.org/10.1371/journal.ppat .1004604
38. Villordo SM, Carballeda JM, Filomatori CV, Gamarnik AV. 2016. RNA structure duplications and flavivirus host adaptation. Trends Microbiol 24:270-283. https://doi.org/10.1016/j.tim.2016.01.002
39. Pijlman GP, Funk A, Kondratieva N, Leung J, Torres S, van der Aa L, Liu WJ, Palmenberg AC, Shi PY, Hall RA, Khromykh AA. 2008. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 4:579-591. https:// doi.org/10.1016/j.chom.2008.10.007
40. Silva PA, Pereira CF, Dalebout TJ, Spaan WJ, Bredenbeek PJ. 2010. An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1. J Virol 84:11395-11406. https://doi.org/10.1128/JVI.01047-10
41. Donald CL, Brennan B, Cumberworth SL, Rezelj VV, Clark JJ, Cordeiro MT, Freitas de Oliveira França R, Pena LJ, Wilkie GS, Da Silva Filipe A, Davis C, Hughes J, Varjak M, Selinger M, Zuvanov L, Owsianka AM, Patel AH, McLauchlan J, Lindenbach BD, Fall G, Sall AA, Biek R, Rehwinkel J, Schnettler E, Kohl A. 2016. Full genome sequence and sfRNA interferon antagonist activity of Zika virus from Recife, Brazil. PLoS Negl Trop Dis 10:e0005048. https://doi.org/10.1371/journal.pntd.0005048
42. Schuessler A, Funk A, Lazear HM, Cooper DA, Torres S, Daffis S, Jha BK, Kumagai Y, Takeuchi O, Hertzog P, Silverman R, Akira S, Barton DJ, Diamond MS, Khromykh AA. 2012. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferonmediated antiviral response. J Virol 86:5708-5718. https://doi.org/ 10.1128/JVI.00207-12
43. Desmyter J, Melnick JL, Rawls WE. 1968. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2:955-961
44. Moon SL, Anderson JR, Kumagai Y, Wilusz CJ, Akira S, Khromykh AA, Wilusz J. 2012. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA 18:2029-2040. https://doi.org/10.1261/rna.034330.112
45. Schnettler E, Sterken MG, Leung JY, Metz SW, Geertsema C, Goldbach RW, Vlak JM, Kohl A, Khromykh AA, Pijlman GP. 2012. Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and mammalian cells. J Virol 86:13486-13500. https://doi.org/10.1128/ JVI.01104-12
46. Moon SL, Dodd BJ, Brackney DE, Wilusz CJ, Ebel GD, Wilusz J. 2015. Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery. Virology 485:322-329. https://doi.org/10.1016/j.virol.2015.08.009
47. Perera-Lecoin M, Meertens L, Carnec X, Amara A. 2013. Flavivirus entry receptors: an update. Viruses 6:69-88. https://doi.org/10.3390/ v6010069
48. Junglen S, Kurth A, Kuehl H, Quan PL, Ellerbrok H, Pauli G, Nitsche A, Nunn C, Rich SM, Lipkin WI, Briese T, Leendertz FH. 2009. Examining landscape factors influencing relative distribution of mosquito genera and frequency of virus infection. Ecohealth 6:239-249. https://doi.org/ 10.1007/s10393-009-0260-y
49. Kümmerer BM, Rice CM. 2002. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol 76:4773-4784. https://doi.org/10.1128/JVI.76.10.4773-4784.2002
50. Bredenbeek PJ, Kooi EA, Lindenbach B, Huijkman N, Rice CM, Spaan WJ. 2003. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol 84: 1261-1268. https://doi.org/10.1099/vir.0.18860-0
51. Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R. 2015. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog 11:e1005277. https://doi.org/10.1371/journal.ppat.1005277
52. Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 40:2323-2330. https://doi.org/ 10.1128/JCM.40.7.2323-2330.2002